APA aipamena

OHASHI, Y., YATABE, M., NIIJIMA, D., TANI, K., OGAWA, C., YACHI, Y., . . . YOKOYAMA, A. (2020). Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma. In Vivo.

Chicago Style aipamena

OHASHI, YASUKATA, et al. "Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma." In Vivo 2020.

MLA aipamena

OHASHI, YASUKATA, et al. "Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma." In Vivo 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.